Quality of life of mastectomized women undergoing immediate breast reconstruction in a cancer referral hospital in Amazonas: a cross-sectional study

Introduction: The assessment of the quality of life is considered important for a more humanistic and comprehensive treatment approach. Methods: This is a descriptive cross-sectional observational study using a quantitative approach. The quality of life of women undergoing immediate breast reconstru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista Brasileira de cirurgia plástica 2020-03, Vol.35 (1), p.38-43
Hauptverfasser: Roberto Alves Pereira, Hilka Flavia Barra do Espírito Santo Alves Pereira, Gabriel Pacífico Seabra Nunes, Edson De Oliveira Andrade, Valbécia Tavares de Aguiar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: The assessment of the quality of life is considered important for a more humanistic and comprehensive treatment approach. Methods: This is a descriptive cross-sectional observational study using a quantitative approach. The quality of life of women undergoing immediate breast reconstruction after mastectomy at the Amazonas Oncology Control Center Foundation (Centro de Controle de Oncologia do Amazonas) from January to June 2015 was assessed. The assessment instrument used was the WHOQOL-BREF questionnaire, following the syntax of the WHOQOL Group. Results: The sociodemographic profiles of 22 patients were evaluated. The predominant age group was 45-49 years, the predominant educational level was high school (63.64%), 90.91% of the patients were from Manaus, and 72.73% were married. A total of 41% of the respondents defined their quality of life as good in the questionnaire, with the physical domain being the most affected and the social relationships domain being the less affected. Conclusion: The assessment of the quality of life should be prioritized in the choice of treatment for breast cancer.
ISSN:1983-5175
2177-1235
DOI:10.5935/2177-1235.2020RBCP0007